RC
SQZ

RBF Capital’s SQZ Biotechnologies Company SQZ Stock Holding History

RBF Capital’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-74,674
Closed -$20.2K – 560
2023
Q2 		$20.2K Hold
74,674
– – ﹤0.01% 525
2023
Q1 		$41.8K Sell
74,674
-53,256
-42% -$39.2K ﹤0.01% 500
2022
Q4 		$94K Sell
127,930
-2,070
-2% -$4.52K 0.01% 503
2022
Q3 		$296K Buy
130,000
+50,000
+63% +$150K 0.02% 411
2022
Q2 		$254K Buy
+80,000
New +$288K 0.02% 440

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RBF Capital's SQZ Position: Q3 2023 in Review

RBF Capital sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 74,674 shares — an estimated $20.2K sold.

RBF Capital first reported a position in SQZ in Q2 2022 and held it in 5 quarters. The position peaked at $296K in Q3 2022. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • RBF Capital reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • RBF Capital sold 74,674 SQZ Biotechnologies Company shares in Q3 2023, an estimated $20.2K.
  • RBF Capital first reported a position in SQZ Biotechnologies Company in Q2 2022 and held it in 5 quarters.
  • RBF Capital's SQZ Biotechnologies Company position peaked at $296K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on RBF Capital's 13F filing for Q3 2023, filed 14 Nov 2023.